Safety of a New Chewable Formulation of Mebendazole for Preventive Chemotherapy Interventions to Treat Young Children in Countries with Moderate-to-High Prevalence of Soil Transmitted Helminth Infections

Table 3

TEAEs observed in at least 1% of the patient population.

	2–5 years	6–10 years	Total
Type of TEAEs	(𝑁=271)	(𝑁=125)	(𝑁=396)
	𝑛 (%)	𝑛 (%)	𝑛 (%)
Total number of children with TEAE	31 (11)	13 (10)	44 (11)
Diarrhea	10 (4)	0	10 (3)
Pyrexia	8 (3)	3 (2)	11 (3)
Lymphadenopathy	5 (2)	3 (2)	8 (2)
Cough	5 (2)	0	5 (1)

TEAE: treatment-emergent adverse event.